Literature DB >> 391258

Comparison of propranolol and metoprolol in the management of hyperthyroidism.

L E Murchison, J How, P D Bewsher.   

Abstract

1 Propranolol and metoprolol were both effective in controlling the symptoms and signs of hyperthyroidism. 2 Propranolol caused a highly significant increase in serum reverse T3 concentrations with lesser changes in other serum thyroid hormone levels, whereas metoprolol did not have this effect. 3 Steady-state plasma propranolol and metoprolol levels showed marked inter-individual variation. Metoprolol concentrations showed relatively little intra-individual variability, and could be related to the clinical efficacy of the drug, whereas no such relationship was demonstrated for propranolol.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 391258      PMCID: PMC1429912          DOI: 10.1111/j.1365-2125.1979.tb01048.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  33 in total

1.  Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.

Authors:  J M Bell; C J Russell; J K Nelson; J G Kelly; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

2.  Statistical methods applied to the clinical diagnosis of thyrotoxicosis.

Authors:  J CROOKS; I P MURRAY; E J WAYNE
Journal:  Q J Med       Date:  1959-04

3.  Achilles-reflex recording with a simple photomotograph.

Authors:  W E GILSON
Journal:  N Engl J Med       Date:  1959-05-14       Impact factor: 91.245

4.  A personality scale of manifest anxiety.

Authors:  J A TAYLOR
Journal:  J Abnorm Psychol       Date:  1953-04

5.  Serum and urine phosphate during short-term beta-adrenergic blockade in healthy men.

Authors:  R Lindsay; L E Ramsay; J Hettiarrachchi; D L Davies; G H Beastall
Journal:  Clin Pharmacol Ther       Date:  1978-12       Impact factor: 6.875

6.  Propranolol influences serum T3 and reverse T3 in hyperthyroidism.

Authors:  P Theilade; J M Hansen; L Skovsted; J Faber; C Kirkegård; T Friis; K Siersbaek-Nielsen
Journal:  Lancet       Date:  1977-08-13       Impact factor: 79.321

7.  Reduction of plasma triiodothyronine (T3) induced by propranolol.

Authors:  G Lotti; G Delitala; L Devilla; S Alagna; A Masala
Journal:  Clin Endocrinol (Oxf)       Date:  1977-06       Impact factor: 3.478

8.  Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism.

Authors:  R P Verhoeven; T J Visser; R Doctor; G Hennemann; M A Schalekamp
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958

9.  Comparative trial of atenolol and propranolol in hyperthyroidism.

Authors:  D G McDevitt; J K Nelson
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

10.  Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors.

Authors:  S Larsson; N Svedmyr
Journal:  Scand J Respir Dis       Date:  1977
View more
  15 in total

Review 1.  Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Authors:  J Feely
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

2.  Serum magnesium, calcium, phosphate and PTH following long-term beta-blockade in ischaemic heart disease.

Authors:  H Perrild; H Jessen-Jürgensen; F Pedersen; N Fogh-Andersen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  The use of a selective beta-adrenergic receptor blocker for the preoperative preparation of thyrotoxic patients.

Authors:  P Dial; P R Hastings
Journal:  Ann Surg       Date:  1982-12       Impact factor: 12.969

4.  A study of long acting propranolol in the early management of hyperthyroidism.

Authors:  G R Jones; J H Lazarus; D Wynford-Thomas
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

5.  Nadolol in thyrotoxicosis.

Authors:  N R Peden; T E Isles; I H Stevenson; J Crooks
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

6.  Beta-adrenoreceptor blocking drugs and thyroid hormones in hyperthyroid subjects.

Authors:  M K Jones; J Birtwell; D R Owens; G R Jones; M Lewis
Journal:  Postgrad Med J       Date:  1981-04       Impact factor: 2.401

Review 7.  The effects of drugs on tests of thyroid function.

Authors:  P H Davies; J A Franklyn
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 8.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

9.  The selective beta 1-blocking agent metoprolol compared with antithyroid drug and thyroxine as preoperative treatment of patients with hyperthyroidism. Results from a prospective, randomized study.

Authors:  A Adlerberth; G Stenström; P O Hasselgren
Journal:  Ann Surg       Date:  1987-02       Impact factor: 12.969

10.  Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients.

Authors:  O R Nilsson; A Melander; L Tegler
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.